|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/06 | |
| A61K 45/06 | |||
| A61K 31/4178 | |||
| A61P 31/12 |
| (11) | Patento numeris | 2488192 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10765917.9 |
| Europos patento paraiškos padavimo data | 2010-10-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-08-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-08-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/051898 |
| Data | 2010-10-08 |
| (87) | Numeris | WO 2011/046811 |
| Data | 2011-04-21 |
| (30) | Numeris | Data | Šalis |
| 250648 P | 2009-10-12 | US | |
| 899840 | 2010-10-07 | US |
| (72) |
LEMM, Julie A., US
VOSS, Stacey A., US
GAO, Min, US
CHANIEWSKI, Susan E., US
SHEAFFER, Amy K., US
MCPHEE, Fiona, US
|
| (73) |
Bristol-Myers Squibb Holdings Ireland,
Hinterbergstrasse 16, 6312 Steinhausen,
CH
|
| (54) | COMBINATIONS OF A SPECIFIC HCV NS5A INHIBITOR AND AN HCV NS3 PROTEASE INHIBITOR |
| COMBINATIONS OF A SPECIFIC HCV NS5A INHIBITOR AND AN HCV NS3 PROTEASE INHIBITOR |